Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

19.98
Delayed Data
As of Sep 04
 -0.01 / -0.05%
Today’s Change
13.73
Today|||52-Week Range
23.95
+22.73%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 24.00, with a high estimate of 25.00 and a low estimate of 23.00. The median estimate represents a +20.12% increase from the last price of 19.98.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.20
Sales
$93.8M
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.60%
 
 
 
 
 
 
Growthannually 39.68%
 
 
 
 
 
 

Sales

Growthquarterly 4.69%
 
 
 
 
 
 
Growthannually 37.47%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.